Synaptogenix Inc (SNPX)

[runncoach]

For over a week now there have been dozens of posts about competing drugs and I've still failed to see a single bit of evidence that any of them have beaten the standard of care or a placebo group, much less anything showing stat significance of the sort so you may be right the two aren't in competition. Neurotrope aims to REVERSE alzheimer's plain and simple. Slowing the rate of deccline isn't in the company's vocabulary. Yes research shows bryostatin could be beneficial for Parkinson's, MS, Fragile X, Rett, NP-C, and TBI but the actual clinical work is showing cognitive improvements and that's not based on any outside or inside party's opinion. It's objective data with proper controls that doesn't have to be massaged. Black and white as Alkon stated. Can't wait to see it published in the coming weeks. Plenty of companies have accredited SAB members and researchers but it comes down to results. I wish the rest well too but I'm not going to conflate hopes with actual results.